On Tuesday, Shares of Walt Disney Co (NYSE:DIS), subtract -0.25% and closed at $97.70 in the last trading session. The last trading range of the stock ranges between $97.42 and $98.14. IMAX Corp. (IMAX), Marvel Television, a unit of Marvel Entertainment, and Disney|ABC Television Group recently declared an innovative agreement to exclusively premiere the new ABC series “Marvel’s The Inhumans” in IMAX commercial theatres, marking the first time a live-action television series has debuted in this manner.
Under the agreement, a version of the first two episodes of Marvel Television’s new series “Marvel’s The Inhumans” – produced in conjunction with ABC Studios and filmed entirely with IMAX digital cameras – will run worldwide exclusively in IMAX for two weeks at the starting of September 2017. ABC plans to then premiere the weekly series in fall, with additional exclusive content that can only be seen on the network.
NuVasive, Inc. (NASDAQ:NUVA), jumped 2.52% and closed at $61.95 in the last trading session. The last trading range of the stock ranges between $59.14 and $62.98. The company’s Market capitalization is $3.10 Billion with the total Outstanding Shares of 50.35 million. NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, counting biologics used for spinal fusion process. The companys principal product is Maximum Access Surgery (MAS), a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, NVM5, and intraoperative monitoring (IMO) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are mainly used to facilitate surgeons access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. Its biologics products are used for spinal fusion or bone healing process, counting Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; Propel DBM, a moldable demineralized bone matrix putty; and Osteocel Plus and Osteocel Pro, an allograft (donated human tissue) cellular matrix. The companys IMO services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It also provides implants; and fixation products, counting pedicle screws, rods, and plates. In addition, the company offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis (EOS), a spinal bracing and distraction system; and PRECICE, a limb lengthening system.